A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.
PHASE4CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
December 31, 1997
Study Completion Date
July 31, 2004
Conditions
Gaucher Disease Type ICerebroside Lipidosis SyndromeClucocerebrosidase Deficiency DiseaseGlucosylceramide Beta-Glucosidase Deficiency DiseaseGaucher Disease, Non-Neuronopathic Form
Interventions
DRUG
Cerezyme (imiglucerase for injection)
Trial Locations (1)
33065
Coral Springs
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00365131 - A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. | Biotech Hunter | Biotech Hunter